Mirror Biologics and Merck KGaA Collaborate on Phase II Trial for Colorectal Cancer Immunotherapy
US-based Mirror Biologics, Inc., an off-the-shelf immunotherapy developer, has announced a clinical trial collaboration and...
US-based Mirror Biologics, Inc., an off-the-shelf immunotherapy developer, has announced a clinical trial collaboration and...
SCG Cell Therapy Pte. Ltd, a Singapore-based company with a presence in Shanghai, has received...
The National Medical Products Administration (NMPA) in China has conditionally approved amimestrocel from Beijing-based Platinum...
China-based CARsgen Therapeutics Holdings Ltd (HKG: 2171) has announced positive results from its pivotal Phase...
Beijing-based firms Immunochina Pharmaceuticals and Cell Store have announced a strategic partnership aimed at bolstering...
China-based Vcanbio Cell & Gene Engineering Corp., Ltd (SHA: 600645) has announced significant progress for...
China-based chimeric antigen receptor T-cell (CAR-T) specialist Immunotech Biopharm Ltd (HKG: 6978) has announced receiving...
Germany-based Fresenius Kabi, a leading name in healthcare, has struck an accord with Ori Biotech...
China-based Legend Biotech Corporation (NASDAQ: LEGN) has released new data on minimal residual disease (MRD)...
Immunofoco, a leading developer in tumor immunotherapy based in Suzhou, has announced that it has...
China-based Precision Biotech has announced a strategic partnership with compatriot firm T&L Biotechnology Co., Ltd....
China-based gene therapy specialist Lingyi Biotechnology Co., Ltd has entered into a comprehensive collaboration agreement...
Beijing-based biotech company Immunochina Pharmaceuticals has announced that the National Medical Products Administration (NMPA) has...
US-based clinical-stage biopharmaceutical company, Poseida Therapeutics (NASDAQ: PSTX), which specializes in donor-derived CAR-T cell therapies,...
Shanghai-based cell therapy specialist Base Therapeutics has achieved clearance from the US Food and Drug...
US-based Alloy Therapeutics Inc. has announced a strategic partnership with Japan-headquartered Takeda Pharmaceutical Co., Ltd...
China-based natural killer (NK) cell therapy developer NK CellTech has entered into a strategic partnership...
China-based Northeast Pharmaceutical Co., Ltd (SHE: 000597) has announced its intention to acquire a 70%...
China-based chimeric antigen receptor (CAR) T cell therapy specialist, Legend Biotech Corporation (NASDAQ: LEGN), has...
Hangzhou-based stem cell specialist Reprogenix has announced the successful completion of a Series A financing...